Buy Tesamorelin 10mg / Ipamorelin 3mg Blend: Dual GH Secretagogue Combination for Research

Tesamorelin 10mg / Ipamorelin 3mg Blend is a research-grade peptide combination formulated to investigate synergistic growth hormone (GH) stimulation through complementary pathways. Tesamorelin, a stabilized GHRH analog, activates pituitary GHRH receptors to promote cAMP-mediated GH synthesis, while Ipamorelin, a selective ghrelin receptor (GHS-R1a) agonist, triggers rapid, pulsatile GH release via calcium-dependent signaling. This dual-mechanism blend supports advanced studies on elevated GH/IGF-1 levels, visceral fat reduction, lean mass preservation, metabolic health, energy balance, sleep quality analogs, and aging-related endocrine processes in experimental models.

Blend Composition: Tesamorelin 10mg + Ipamorelin 3mg (13mg total per vial) Purity: ≥99% (lyophilized, third-party tested) Form: Research use only – lyophilized powder for reconstitution

Important Notice: This peptide blend is strictly intended for research and laboratory use only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes. Please review and agree to our Terms and Conditions before ordering.

What is the Tesamorelin / Ipamorelin Blend?

This combination merges two well-characterized GH secretagogues with distinct yet synergistic receptor targets:

• Tesamorelin — A 44-amino-acid GHRH analog modified for enzymatic resistance, known for selective pituitary GH stimulation and preferential visceral lipolytic effects in metabolic models.
• Ipamorelin — A pentapeptide ghrelin mimetic that potently activates GHS-R1a with minimal impact on cortisol, prolactin, or appetite stimulation in many research contexts.

The blend is explored for potential additive or synergistic amplification of GH pulses, more sustained IGF-1 elevation, and enhanced endocrine-metabolic signaling compared to single-agent administration.

Mechanism of Action in Research

The combination leverages dual pathway activation:

• Tesamorelin → GHRH receptor → ↑ cAMP/PKA → regulated GH synthesis & release
• Ipamorelin → Ghrelin receptor (GHS-R1a) → ↑ intracellular Ca²⁺ → rapid, pulsatile GH secretion

This complementary signaling may result in more physiological GH patterns, improved axis regulation, reduced feedback suppression, and broader downstream effects on lipolysis, protein synthesis, and metabolic homeostasis.

Key Research Areas and Potential Insights

The Tesamorelin/Ipamorelin blend is of interest in endocrine, metabolic, and age-related research.

Growth Hormone & IGF-1 Axis Modulation

Studies examine amplified pulsatile GH output, elevated IGF-1/IGFBP-3 levels, and optimization of the somatotropic axis in models of GH deficiency or age-related decline.

Visceral Fat Reduction & Body Composition

Research investigates targeted lipolysis in visceral adipose tissue, preservation of lean body mass, and favorable changes in fat distribution.

Metabolic Health & Energy Balance

Explorations include impacts on lipid profiles, insulin sensitivity markers, basal metabolic rate, and nutrient partitioning.

Aging, Recovery & Cognitive Models

Additional investigations assess potential neurotrophic effects, sleep architecture analogs, tissue repair support, and resilience in aging-related experimental systems.

Research Applications

The 10mg/3mg blend vial supports:

• In-vitro and in-vivo GH/IGF-1 secretion and pulsatility assays
• Adipose metabolism, lipolysis, and body composition studies
• Endocrine aging, metabolic syndrome, and hormone restoration models
• Synergy, dose-response, pharmacokinetics, and chronic exposure experiments

Reconstitution typically uses bacteriostatic water for precise concentrations in lab protocols.

Why Choose 99% Pure Tesamorelin 10mg / Ipamorelin 3mg Blend?

This blend delivers ≥99% purity for consistent, reproducible results in pituitary signaling, GH release kinetics, and metabolic endpoint studies. Vacuum-sealed and third-party verified to ensure experimental integrity.

In summary, the Tesamorelin 10mg / Ipamorelin 3mg Blend is a premium dual GH secretagogue combination for cutting-edge research into synergistic growth hormone stimulation, visceral fat loss, lean mass preservation, metabolic optimization, and aging-related endocrine pathways. Advance your hormonal and regenerative investigations with this targeted peptide tool.

Latest Testing: Link to Report